A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Abigale Clark's research focuses on dermatological conditions and their treatment. Her recent publications investigate the efficacy of tofacitinib in treating sarcoidosis, review therapeutic management for keratoacanthomas, and report on pyoderma gangrenosum recurrence potentially triggered by COVID-19 vaccination. She has also published on Mohs micrographic surgery for dermatofibrosarcoma protuberans, severe cutaneous adverse reactions to lamotrigine, patient perspectives on granuloma annulare, olaparib-induced pseudoporphyria, and minocycline-induced nail pigmentation. Clark's work includes a case series of 15 patients and explores patient experiences with specific conditions. Her scholarship metrics include an h-index of 5 with 149 total citations across 10 publications. She has collaborated with Blake St. Clair at the University of Arkansas for Medical Sciences on two shared publications.
Metrics
- h-index: 5
- Publications: 10
- Citations: 155
Selected Publications
-
Olaparib-induced pseudoporphyria in a patient with ovarian cancer (2023)
-
Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience (2022)
Collaboration Network
Top Collaborators
Austin Ambur
Advanced Dermatology & Cosmetic Surgery (US)
2 shared publications
- An Updated Review of the Therapeutic Management of Keratoacanthomas.
- Isolated Nail Pigmentation Induced by Minocycline: A Case Report
Rajiv Nathoo
Advanced Dermatology & Cosmetic Surgery (US)
2 shared publications
- An Updated Review of the Therapeutic Management of Keratoacanthomas.
- Isolated Nail Pigmentation Induced by Minocycline: A Case Report
Blake St. Clair
University of Arkansas for Medical Sciences
2 shared publications
In database
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
- Severe Cutaneous Adverse Reactions Associated With High-Dose Lamotrigine for Mood Disorders: A Case Series
William Damsky
Yale University (US)
2 shared publications
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
- Patient perspectives on the lived experience of granuloma annulare
Michael J. Murphy
2 shared publications
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
- Patient perspectives on the lived experience of granuloma annulare
Brett King
2 shared publications
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
- Patient perspectives on the lived experience of granuloma annulare
Blake Williams
Kansas City University (US)
1 shared publication
- Recurrence of Pyoderma Gangrenosum Potentially Triggered by COVID-19 Vaccination
Benjamin Rollins
University of Arkansas for Medical Sciences (US)
1 shared publication
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
Thomas A. Jennings
University of Arkansas for Medical Sciences (US)
1 shared publication
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
Alice Wang
Yale University (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Daniel Kim
Yale University (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Bryan D. Young
Yale University (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Katelyn Singh
Yale University (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Joseph A. Daccache
Yale University (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Rüveyda Ayasun
NYU Langone Health (US)
1 shared publication
- Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Similar Researchers
Based on overlapping research topics
Elsherbini, Medhat
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
SARS-CoV-2 and COVID-19 Research
Lauren C. Morehead
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
Horace J. Spencer
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
SARS-CoV-2 and COVID-19 Research
Cancer Treatment and Pharmacology
Daphne Macbruce
University of Arkansas – Fort Smith
Dermatology and Skin Diseases
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
N. S. Kumar
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
Luísa Camacho
National Center for Toxicological Research
Dermatology and Skin Diseases
Pharmacological Effects and Toxicity Studies
SARS-CoV-2 and COVID-19 Research